A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic

A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic

Source :

• Vaccine [ 0264-410X ] ; 2009.

Descripteurs français

• KwdFr :
  • ARN double brin (génétique), ARN viral (génétique), Administration par voie nasale, Animaux, Anticorps antiviraux (génétique), Anticorps antiviraux (immunologie), Flambées de maladies, Grippe chez les oiseaux (génétique), Grippe chez les oiseaux (immunologie), Grippe chez les oiseaux (virologie), Grippe humaine (immunologie), Grippe humaine (épidémiologie), Humains, Mâle, Oiseaux, Récepteur de type Toll-3 (génétique), Réplication virale, Souris, Souris de lignée BALB C, Sous-type H5N1 du virus de la grippe A (génétique), Sous-type H5N1 du virus de la grippe A (immunologie), Sous-type H5N1 du virus de la grippe A (pathogénicité), Vaccins antigrippaux (administration et posologie), Vaccins antigrippaux (génétique), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (usage thérapeutique), Vaccins inactivés (génétique), Vaccins inactivés (immunologie).
• MESH :
  • administration et posologie : Vaccins antigrippaux.
  • génétique : ARN double brin, ARN viral, Anticorps antiviraux, Grippe chez les oiseaux, Récepteur de type Toll-3, Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux, Vaccins inactivés.
  • immunologie : Anticorps antiviraux, Grippe chez les oiseaux, Grippe humaine, Sous-type H5N1 du virus de la grippe A, Vaccins antigrippaux, Vaccins inactivés.
  • pathogénicité : Sous-type H5N1 du virus de la grippe A.
  • usage thérapeutique : Vaccins antigrippaux.
  • virologie : Grippe chez les oiseaux.
  • épidémiologie : Grippe humaine.
• Pascal (Inist)
  • Administration par voie nasale, Animaux, Flambées de maladies, Humains, Influenzavirus, Mâle, Oiseaux, Réplication, Adjuvant immunologique, Immunoprophylaxie, Grippe, Réplication virale, Souris, Souris de lignée BALB C.

English descriptors

• KwdEn :
  • Administration, Intranasal, Animals, Antibodies, Viral (genetics), Antibodies, Viral (immunology), Birds, Disease Outbreaks, Humans, Immunological adjuvant, Immunoprophylaxis, Influenza, Influenza A Virus, H5N1 Subtype (genetics), Influenza A Virus, H5N1 Subtype (immunology), Influenza A Virus, H5N1 Subtype (pathogenicity), Influenza Vaccines (administration & dosage), Influenza Vaccines (genetics), Influenza Vaccines (immunology), Influenza Vaccines (therapeutic use), Influenza in Birds (genetics), Influenza in Birds (immunology), Influenza in Birds (virology), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenzavirus, Male, Mice, Mice, Inbred BALB C, RNA, Double-Stranded (genetics), RNA, Viral (genetics), Replication, Toll-Like Receptor 3 (genetics), Vaccines, Inactivated (genetics), Vaccines, Inactivated (immunology), Virus Replication.
• MESH :
  • chemical , administration & dosage : Influenza Vaccines.
  • chemical , genetics : Antibodies, Viral, Influenza Vaccines, RNA, Double-Stranded, RNA, Viral, Toll-Like Receptor 3, Vaccines, Inactivated.
  • chemical , immunology : Antibodies, Viral, Influenza Vaccines, Vaccines, Inactivated.
  • epidemiology : Influenza, Human.
  • genetics : Influenza A Virus, H5N1 Subtype, Influenza in Birds.
  • immunology : Influenza A Virus, H5N1 Subtype, Influenza in Birds, Influenza, Human.
  • pathogenicity : Influenza A Virus, H5N1 Subtype.
  • chemical , therapeutic use : Influenza Vaccines.
  • virology : Influenza in Birds.
  • Administration, Intranasal, Animals, Birds, Disease Outbreaks, Humans, Male, Mice, Mice, Inbred BALB C, Virus Replication.

Abstract

• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115584

Affiliations:

• Singapour

Links toward previous steps (curation, corpus...)

• to stream PascalFrancis, to step Corpus: 001849
• to stream PascalFrancis, to step Curation: 000650
• to stream PascalFrancis, to step Checkpoint: 001769
• to stream Main, to step Merge: 004726
• to stream Pmc, to step Corpus: 000E30
• to stream Pmc, to step Curation: 000E30
• to stream Pmc, to step Checkpoint: 000C58
• to stream PubMed, to step Corpus: 001827
• to stream PubMed, to step Curation: 001827
• to stream PubMed, to step Checkpoint: 001697
• to stream Ncbi, to step Merge: 000813
• to stream Ncbi, to step Curation: 000813
• to stream Ncbi, to step Checkpoint: 000813
• to stream Main, to step Merge: 004086
• to stream Main, to step Curation: 004478

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004478 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004478 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:09-0167946
   |texte=   A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic
}}

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021